-
First IPO Application Accepted under the Reinstated Fifth Set of STAR Market Listing Standards
-
STAR Market Companies Showcase at World Artificial Intelligence Conference, Unleashing New Momentum for Intelligent Manufacturing in China
-
Potential Deal Exceeds $10 Billion: Hengrui Pharmaceuticals Secures Major Overseas Licensing Agreement
-
China's First Publicly Offered REIT for a Headquarters-Based Sci-Tech Industrial Park Listed on SSE
-
Fruitful Results of Four-Year Hard Work: China's REIT Market Value Totals Over 200 Billion Yuan, with SSE Establishing a Main Platform for REIT Market Development
-
Restart of IPO Review under the SSE STAR Market's Fifth Set of Standards, with Healthgen Biotechnology to Be Reviewed by the Listing Review Committee
-
Offering of the First Clean Energy Holding-type Real Estate ABS and SSE's Establishment of a Multi-level REIT Market for Promoting Green Finance
-
SSE Series Indexes Perform Outstandingly, Helping to Build a Market Ecosystem of "Long-term Funds for Long-term Investment"
-
First Anniversary of the "Eight Measures": Over 30 Reforms Drive New Quality Productive Forces in the SSE STAR Market
-
Nearly 60 Scientific Research Results of Innovative Pharmaceutical Companies on the STAR Market Attract Global Attention
-
The STAR Market Eight Measures Stimulates Index-based Investing and Channels Financial Resources Towards Technology Sector
-
140,000 Employees of Companies Listed on the SSE STAR Market Received Equity Incentives as R&D Investment Soared 10.7% over Three Years
-
Looking Back at the Eight Measures on Deepening the SSE STAR Market Reform and Supporting Scientific and Technological Innovation and the Development of New Quality Productive Forces–A New Start for Reform|"Light-Asset, High-R&D" Refinancing Gathers Pace, Boosting Innovation on the SSE STAR Market